Rhythm Pharmaceuticals (RYTM) Tax Provisions (2021 - 2026)
Rhythm Pharmaceuticals (RYTM) posted quarterly Tax Provisions of $500000.0 for Q1 2026, up 400.0% year-over-year from $100000.0 in Q1 2025, and up 1712.9% quarter-over-quarter from -$31000.0 in Q4 2025.
Rhythm Pharmaceuticals (RYTM) Tax Provisions (2021 - 2026) Analysis & Trends
Rhythm Pharmaceuticals (RYTM) has reported Tax Provisions for 5 consecutive years, with $500000.0 the latest figure, recorded in Q1 2026.
- In Q1 2026, Tax Provisions rose 400.0% year-over-year to $500000.0; the TTM figure through Mar 2026 stood at $880000.0 (up 335.64% YoY), while the FY2025 annual figure was $497000.0, up 43.64% from the prior year.
- Tax Provisions climbed to $500000.0 in Q1 2026 per RYTM's latest filing, from -$31000.0 in the prior quarter.
- Across five years, Tax Provisions topped out at $500000.0 in Q2 2024 and bottomed at -$344000.0 in Q3 2024.
- Historically, Tax Provisions has averaged $176909.1 across 4 years, with a median of $196000.0 in 2023.
- Annual changes were most pronounced in 2024 — Tax Provisions sank 193.48% — and 2026, when it surged 400.0%.
- Rhythm Pharmaceuticals' Tax Provisions stood at $196000.0 in 2023, then slumped by 127.55% to -$54000.0 in 2024, then soared by 42.59% to -$31000.0 in 2025, then jumped by 1712.9% to $500000.0 in 2026.
- Business Quant data shows RYTM's Tax Provisions at $500000.0 in Q1 2026, -$31000.0 in Q4 2025, and $111000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 292.00 Mn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 230.90 Mn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 59.00 Mn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 75.45 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 267.73 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 13.31 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 1.90 Mn |
| 10 | Rhythm Pharmaceuticals | 7.95 Bn | 7.62 Bn | 62.32 Mn | 444,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 444,000.00 |
| Mar 31, 2026 | 500,000.00 |
| Dec 31, 2025 | -31,000.00 |
| Sep 30, 2025 | 111,000.00 |
| Jun 30, 2025 | 300,000.00 |
| Mar 31, 2025 | 100,000.00 |
| Dec 31, 2024 | -54,000.00 |
| Sep 30, 2024 | -344,000.00 |
| Jun 30, 2024 | 500,000.00 |
| Mar 31, 2024 | 300,000.00 |
| Dec 31, 2023 | 196,000.00 |
| Sep 30, 2023 | 368,000.00 |
| Sep 30, 2021 | -9.00 Mn |
| Jun 30, 2021 | -5.02 Mn |
| Mar 31, 2021 | 22.01 Mn |